These findings reveal the 9-1-1 complex, and its loader RAD17, as critical for compensatory ssDNA repair in BRCA2-deficient cancer cells, presenting potentially promising therapeutic targets for selective killing of these tumors. The gene discussed is BRCA2; the disease is cancer.